BeyondSpring may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter. As of now, BeyondSpring's Non Current Liabilities Total is increasing as compared to previous years. The BeyondSpring's current Capital Surpluse is estimated to increase to about 298.2 M, while Short and Long Term Debt Total is projected to decrease to under 503.6 K.
Investors should never underestimate BeyondSpring's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to research BeyondSpring's cash flow, debt, and profitability to make informed and accurate decisions about investing in BeyondSpring.
Understanding current and past BeyondSpring Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of BeyondSpring's financial statements are interrelated, with each one affecting the others. For example, an increase in BeyondSpring's assets may result in an increase in income on the income statement.
BeyondSpring competes with Alx Oncology, ImmunoPrecise Antibodies, ATyr Pharma, Precision BioSciences, and Fractyl Health. BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company was founded in 2010 and is headquartered in New York, New York. Beyondspring operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 103 people.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
Comparative valuation techniques use various fundamental indicators to help in determining BeyondSpring's current stock value. Our valuation model uses many indicators to compare BeyondSpring value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BeyondSpring competition to find correlations between indicators driving BeyondSpring's intrinsic value. More Info.
BeyondSpring is rated below average in return on equity category among its peers. It is number one stock in return on asset category among its peers . As of now, BeyondSpring's Return On Equity is increasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BeyondSpring's earnings, one of the primary drivers of an investment's value.
Most indicators from BeyondSpring's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into BeyondSpring current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BeyondSpring. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.
BeyondSpring is part of Cancer Fighters investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Public companies from health care and pharmaceutical sectors that are focused on fighting cancer. Biotech and medical diagnostic companies that work on researching drugs or manufacturing of medical and therapeutics equipment that is directly related to the research, treatment, and detection of cancer or cancer related diseases
This theme covers Public companies from health care and pharmaceutical sectors that are focused on fighting cancer. Biotech and medical diagnostic companies that work on researching drugs or manufacturing of medical and therapeutics equipment that is directly related to the research, treatment, and detection of cancer or cancer related diseases. Get More Thematic Ideas
Today, most investors in BeyondSpring Stock are looking for potential investment opportunities by analyzing not only static indicators but also various BeyondSpring's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of BeyondSpring growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of BeyondSpring help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of BeyondSpring. We use our internally-developed statistical techniques to arrive at the intrinsic value of BeyondSpring based on widely used predictive technical indicators. In general, we focus on analyzing BeyondSpring Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build BeyondSpring's daily price indicators and compare them against related drivers.
Complementary Tools for BeyondSpring Stock analysis
When running BeyondSpring's price analysis, check to measure BeyondSpring's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BeyondSpring is operating at the current time. Most of BeyondSpring's value examination focuses on studying past and present price action to predict the probability of BeyondSpring's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BeyondSpring's price. Additionally, you may evaluate how the addition of BeyondSpring to your portfolios can decrease your overall portfolio volatility.